Frank P. Vendetti

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression”.

Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression

Cell Reports(2022)10.1016/j.celrep.2022.111371

N/A

0DataRank · unranked

25 citations

Frank P. Vendetti, Andrew J. Cipriano, Pinakin Pandya, Joshua J. Deppas, Tatiana N. Moiseeva +12 more

Thymidine rescues ATR kinase inhibition induced deoxyuridine contamination in genomic DNA, cell death, and Type 1 interferon expression

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.24.481821

N/A

0DataRank · unranked

1 citations

Frank P. Vendetti, Andrew J. Cipriano, Pinakin Pandya, Joshua J. Deppas, Tatiana N. Moiseeva +12 more

Short-course but not prolonged treatment with ATR inhibitor AZD6738 integrates with radiotherapy to generate a tumor antigen-specific CD8 + T cell expansion in the periphery

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.11.487886

N/A

0DataRank · unranked

0 citations

D.A. Clump, Sandra Schamus-Haynes, Maria diMayorca, Naveed M. Islam, Jina Chang +3 more

The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy

JCI Insight(2023)10.1172/jci.insight.165615

N/A

0DataRank · unranked

36 citations

Pinakin Pandya, David A. Clump, Sandra Schamus-Haynes, Meysam Tavakoli, Maria diMayorca +6 more

Deoxyuridine-rich cytoplasmic DNA antagonizes STING-dependent innate immune responses and sensitizes resistant tumors to anti-PD-L1 therapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.04.588079

N/A

0DataRank · unranked

1 citations

Frank P. Vendetti, Joseph El-Ghoubaira, Sudipta Pathak, Joshua J. Deppas, Reyna Jones +12 more

Nuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cells

Neuro-Oncology(2025)10.1093/neuonc/noaf110

N/A

0DataRank · unranked

5 citations

Suchet Taori, Shruti Bhargava, Sisi Lai, Cuiqing Zhong, Shira Yomtoubian +20 more

Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiation

Toxicology and Applied Pharmacology(2025)10.1016/j.taap.2025.117375

N/A

0DataRank · unranked

4 citations

Brian F. Kiesel, Jianxia Guo, Lora H. Rigatti, Joseph D. Latoche, Anthony R. Green +7 more

Zinc availability in the tumor microenvironment dictates anti-PD1 response in CDKN2A Low tumors via increased macrophage phagocytosis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.08.637227

N/A

0DataRank · unranked

3 citations

Aidan R. Cole, Jeff Danielson, Jimmy P. Xu, Drew E. Hurd, Akash Kishore +33 more

Uracil-DNA glycosylase deficiency is associated with repressed tumor cell-intrinsic inflammatory signaling and altered sensitivity to exogenous interferons

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.28.666960

N/A

0DataRank · unranked

1 citations

Pinakin Pandya, Carina R. Sclafani, Reyna Jones, D. Ivanov, Robert W. Sobol +2 more

Uracil-DNA glycosylase deficiency is associated with repressed tumor cell-intrinsic inflammatory signaling and altered sensitivity to exogenous interferons

NAR Cancer(2025)10.1093/narcan/zcaf054

N/A

0DataRank · unranked

0 citations

Pinakin Pandya, Carina R. Sclafani, Sudipta Pathak, Raquel Buj, Reyna Jones +5 more